Delivery Order SPE2DR25D1202-SPE2DR26F72AZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,078.40 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens on November 5, 2025, with an ultimate completion date of November 6, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens valued at $5,564.41. This delivery order, issued under a firm fixed-price contract with no set-aside designation, is due for completion by July 14, 2025. AmerisourceBergen will fulfill this order from its corporate office in Conshohocken, Pennsylvania, where the company maintains operations as a primary pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors valued at $10,552.44 under a firm fixed-price contract. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens in 0.5 ml quantities, valued at $28,003.89. This firm fixed-price delivery order, with an ultimate completion date of October 22, 2025, carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens valued at $1,632.54 with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under the company's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $7,755.60 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pens on August 7, 2025, with completion targeted for August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens valued at $2,313.04, with completion scheduled for October 27, 2025. This non-competitive, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate headquarters location in...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pens valued at $5,094.18. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, issued on September 4, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens with a ceiling value of $26,411.84. This firm fixed price delivery order represents a non-competitive award and is scheduled for completion by September 29, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens valued at $1,904.63 with a completion date of June 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72AZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pens with a ceiling value of $1,317.10. This non-set-aside, firm fixed-price delivery order is scheduled for completion by November 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The product delivery supports the military and federal healthcare supply chain, consistent with the Defense Logistics Agency's Medical Supply Chain operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical federal medical procurement vendor for military healthcare systems and other government health agencies through this IDC vehicle, which enables flexible ordering of a broad range of pharmaceutical products and medical supplies to support worldwide military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/7/25 |